Business
Loblaw adds independent advisors to Patient Care and Quality Committee as it supports access to healthcare for Canadians
Loblaw adds independent advisors to Patient Care and Quality Committee as it supports access to h...
About this update from Loblaw Companies Limited
[{"type":"text","content":"\n\n\n\n Loblaw adds independent advisors to Patient Care and Quality Committee as it supports access to healthcare for Canadians\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n Committee provides enhanced oversight of patient care and quality\n \n\n that is separate from business management\n \n\n\n\n\n BRAMPTON, ON\n \n\n ,\n \n\n March 28, 2025\n \n\n /CNW/ - Loblaw Companies Limited (TSX: L) (\"Loblaw\" or \"the Company\") today announced the appointment of three external healthcare advisers to its Patient Care and Quality Committee (\"the Committee\") of the Board of Directors.\n \n\n For two decades, pharmacists have been responding to an urgent need for more accessible healthcare.  What began with administering flu shots in 2007, has become an important part of how Loblaw and Shoppers Drug Mart pharmacists are doing their part for patients who are increasingly turning to their local pharmacists for proven, convenient care for a growing number of specific acute and chronic conditions.\n \n\n The Company is a strong supporter of universal access to care within\n \n Canada's\n \n single payor system. It is focused on continuing to adhere to the highest standards of care. The Committee takes its inspiration from public health systems across\n \n Canada\n \n and provides oversight, separate from business management, for quality improvement, risk management and incident response across Shoppers Drug Mart, Loblaw Pharmacies and Lifemark. It complements essential provincial regulatory oversight already in place in every jurisdiction in the country.\n \n\n Formed in\n \n January 2025\n \n , the Committee will benefit from each of the newly appointed advisors' experience in quality care delivery:\n \n\n\n\n Adalsteinn Brown\n \n , PhD:\n \n Currently Dean of the Dalla Lana School of Public Health at the\n \n University of Toronto\n \n , Dr. Brown has extensive experience in healthcare policy and governance, having previously served in the Ontario Ministry of Health where he drafted legislation gov...